Related Experiment Video
Updated: Jan 17, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
TB-Related Stigma: A Hidden Obstacle to Adherence Monitoring with Video Directly Observed Treatment Among Patients
Kelvin Bwambale1, Damalie Nakkonde1, Gloria Nassanga1
1Makerere University.
Background:
Adherence to video directly observed treatment (VDOT) remains inconsistent, with some patients frequently missing video submissions. Stigma associated with tuberculosis (TB) may influence patients' engagement with VDOT, leading to non-adherence. This study examines the effect of baseline TB-related stigma on missed VDOT submissions as a marker of patient engagement throughout treatment among patients with TB.
Methods:
This study was a secondary analysis of 71 patients with TB from the DOT Selfie Randomized clinical trial (RCT) in Kampala, Uganda (July 2020-October 2021). It focused on the association between baseline TB-related stigma and missed video submissions during six months of VDOT. Stigma was measured using a 13-item tool covering self-, anticipated, and public stigma. Self-stigma is when individuals believe and internalize negative views about TB, causing shame and avoiding care. Public stigma involves harmful attitudes and discrimination from others, leading to isolation. Anticipated stigma is the fear of being judged or treated unfairly if one's TB status becomes known. Four negative binomial regression models adjusted for HIV status, alcohol use, household size, marital status, and TB severity were used to estimate adjusted incidence rate ratios (aIRR) with their 95% confidence intervals (CIs) using STATA 14.2.
Results:
The study included 71 patients with TB with a mean age of 33 years (SD = 12), and 36 (51%) were female. TB-related stigma was highly prevalent, with 51% (95% CI: 39-62) experiencing high levels of overall stigma. The prevalence of public stigma was 97% (95% CI: 90-100), self-stigma was 80% (95% CI: 22-45), and anticipated stigma was 68% (95% CI: 55-78). High overall stigma was significantly associated with an increase in the rate of missed VDOT videos (aIRR = 1.9; 95% CI: 1.1-3.5). Similarly, patients who reported anticipated stigma missed twice as many VDOT videos as those without anticipated stigma (aIRR: 2.1; 95% CI: 1.2-3.8). There was no significant association between self and public stigma and missed videos.
Conclusion:
TB-related stigma, particularly the anticipated fear of judgment, undermines VDOT adherence monitoring. Interventions such as early screening for stigma, patient counselling, and community education are essential to improving outcomes.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Therapeutic Drug Monitoring: Affecting Factors
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

